A questionnaire survey on the mentality and behavior of patients with type 2 diabetes duringCOVID-19 pandemic period

doi:10.3969/j.issn.1006-7795.2020.06.017

Abstract

Abstract: Objective To investigate the behavior changes and psychological fluctuation of patients with type 2 diabetes during theCOVID-19 pandemic period pandemic period, and to provide basis for better glucose management, psychological, behavioral guidance. Methods Totally 576 type 2 diabetic patients were subjected from the National Metabolic Management Center(MMC)in Beijing Luhe Hospital, based on the in-house questionnaires, Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder assessment (GAD-7) for the cross sectional analysis. The incidence of anxiety and depression was compared with that of type 2 diabetic patients who were not under MMC management during the same period. Results During 2019-nCoV pandemic period, 68.4% of the patients' fingertip glucose level was controlled well in the past two weeks, with fasting blood glucose at 4.4-7.0 mmol/L and 2-hour postprandial blood glucose below 10 mmol/L. 69.1% of type 2 diabetic patients had less physical exercise than before. The prevalence of anxiety and depression of the type 2 diabetic patients under the MMC management was 27.1% and 23.6%, respectively, lower than those without MMC management during the same period. Patients who lived alone(OR=0.393,95%CI:0.160-0.965), and who had one or more comorbidities (OR=15.544, 95%CI:9.632-25.084)were at high risk of anxiety(All P＜0.05). Those who were younger(OR=0.541, 95%CI: 0.389-0.751), lived alone(OR=0.398, 95%CI:0.167-0.948), had one or more comorbidities (OR=7.409, 95%CI:4.962-11.065),and had poor blood glucose control (OR=0.659, 95%CI:0.506-0.859) were at higher risk of depression(All P＜0.05). Conclusions During the epidemic period, the incidence of anxiety and depression in type 2 diabetic patients under MMC management was lower than that of patients not under MMC management, and blood glucose of the former was basically well controlled. The patients had a good knowledge of the 2019-nCoV. The cognition and behavior pattern of most patients managed by MMC were positive.

Key words: 2019-nCoV, type 2 diabetes, national metabolic management center, anxiety, depression

CLC Number:

R587

Yin Xingqi, Yu Caiguo, Ke Jing, Zhao Dong, Yu Ke. A questionnaire survey on the mentality and behavior of patients with type 2 diabetes duringCOVID-19 pandemic period[J]. Journal of Capital Medical University, 2020, 41(6): 970-977.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2020.06.017

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2020/V41/I6/970

References

[1] 杨娟, 赖圣杰, 余宏杰. 感染性疾病流行现状、防控挑战与应对[J]. 中华疾病控制杂志, 2017,21(7):647-649, 674.
[2] 国家卫生健康委员会, 国家中医药管理局. 新型冠状病毒肺炎诊疗方案(试行第七版)[J]. 江苏中医药, 2020,52(4):1-6.
[3] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020,395(10223):507-513.
[4] Ranganath M, Sriram G. COVID-19 pandemic, coronaviruses, and diabetes mellitus[J]. Am J Physiol Endocrinol Metab, 2020 318(5):E736-E741.
[5] World Health Orgnization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation, 2006[M]. Geneva: WHO Document Production Services, 2006.
[6] Kroenke K, Spitzer R L, Williams J B. The PHQ-9: validity of a brief depression severity measure[J]. J Gen Intern Med, 2001,16(9):606-613.
[7] Spitzer R L, Kroenke K, Williams J B, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7[J]. Arch Intern Med, 2006,166(10):1092-1097.
[8] Qiu J, Shen B, Zhao M, et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations[J]. Gen Psychiatr, 2020,33(2):e100213.
[9] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020,395(10223):507-513.
[10]Wang L, He W, Yu X, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up[J]. J Infect, 2020,80(6):639-645.
[11]Furuya M, Hayashino Y, Tsujii S, et al. Comparative validity of the WHO-5 Well-Being Index and two-question instrument for screening depressive symptoms in patients with type 2 diabetes[J]. Acta Diabetol, 2013,50(2):117-121.
[12]Gois C J, Ferro A C, Santos A L, et al. Psychological adjustment to diabetes mellitus: highlighting self-integration and self-regulation[J]. Acta Diabetol, 2012,49(Suppl 1):S33-S40.
[13]冯艳春, 刘娜, 刘继霞, 等. 用 GAD-7和 PHQ-9调查分析综合医院住院患者的焦虑抑郁状况[J]. 齐齐哈尔医学院学报, 2015(32):4926-4927.
[14]吴金凤, 吴夏鑫, 李双, 等. 2型糖尿病患者焦虑、抑郁与血糖控制的关联及其临床护理[J]. 实用临床医药杂志, 2019,23(6):62-65.
[15]高兴,刘海燕,陈丽萍,等.老年2型糖尿病患者合并焦虑和抑郁的相关影响因素分析[J].解放军医药杂志,2019,31(12):77-80.
[16]Semenkovich K, Brown M E, Svrakic D M, et al. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment[J]. Drugs, 2015,75(6):577-587.
[17]Shinkov A, Borissova A M, Kovatcheva R, et al. Increased prevalence of depression and anxiety among subjects with metabolic syndrome and known type 2 diabetes mellitus-a population-based study[J]. Postgrad Med, 2018,130(2):251-257.
[18]纪立农, 李光伟, 巩秋红, 等. 新型冠状病毒肺炎疫情期间老年糖尿病患者疾病管理与应急指引[J]. 中国糖尿病杂志, 2020,28(1):1-6.
[19]中国老年保健医学研究会老年内分泌与代谢病分会编写组. 新型冠状病毒肺炎疫情期间老年糖尿病患者疾病管理与应急指引[J]. 中国糖尿病杂志, 2020,28(1):1-6.
[20]Hashim N A, Ariaratnam S, Salleh M R, et al. Depression and associated factors in patients with type 2 diabetes mellitus[J]. East Asian Arch Psychiatr, 2016,26(2):77-82.
[21]Arshad A R, Alvi K Y. Frequency of depression in type 2 diabetes mellitus and an analysis of predictive factors[J]. J Pak Med Assoc, 2016,66(4):425-429.
[22]AlBekairy A, AbuRuz S, Alsabani B, et al. Exploring factors associated with depression and anxiety among hospitalized patients with type 2 diabetes mellitus[J]. Med Princ Pract, 2017,26(6):547-553.